Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Chemotherapy can be more toxic to brain cells than to cancer cells and may cause long-term brain damage

Drugs used to treat cancer may damage normal, healthy brain cells more than the cancer cells they are meant to target.

A study published today in the open access journal Journal of Biology shows that clinical doses of chemotherapeutic drugs used to treat many common cancers cause long-term damage to the brains of mice by killing neural stem cells and oligodendrocytes, which produce the myelin insulation needed for normal neuronal function, and by impairing neural stem cell division. These results might explain the adverse neurological side effects - including reduction in cognitive abilities - observed in some cancer patients treated with chemotherapy. The approach used in the current study could also provide a rapid screening method to analyse new therapies and identify cell populations at risk during cancer treatment.

Joerg Dietrich and colleagues working in the group of Mark Noble, from the University of Rochester in the USA, exposed human neural stem cells, oligodendrocyte precursor cells and neuron-restricted precursor cells, in culture, to three chemotherapeutic agents: cisplatin, carmustine and cytarabine. Dietrich et al. also exposed different human cancer cell lines, such as uterine, breast or colon cancer cell lines to the same chemotherapeutic agents. Cisplatin is used to treat a wide range of cancers, including breast cancer, lung cancer and colon cancer and carmustine is used to treat brain tumours, Hodgkin and non-Hodgkin lymphomas. Both agents act by modifying the structure of DNA. Cytarabine, which interferes with cell metabolism, is used to treat leukaemia and lymphomas.

Dietrich et al.’s results show that clinical concentrations of cisplatin, carmustine and cytarabine are more toxic to human neural cells than to cancer cells. The drugs are toxic to both the dividing neural stem cells and the non-dividing cells such as astrocytes and neurons, even at very low concentrations. Results show that exposure to low micromolar concentrations of cisplatin, carmustine or cytarabine causes a 60-90% reduction in the viability of oligodendrocyte precursor cells and neuron precursor cells, but has little effect on most of the cancer cell lines examined. The authors show that to kill 40-80% of cancer cells, doses that also kill 70-100% of neural cells are required.

Using live mice treated with each of the drugs, Dietrich et al. show that cells of the nervous system of the mice continue to die for at least six weeks after the end of treatment. The drugs kill both dividing stem cells and non-dividing precursor cells of the nervous system in live mice. They also cause long-lasting reductions in cell division and proliferation in the central nervous system of the mice.

Juliette Savin | alfa
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>